38 results
424B3
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
29 Dec 23
Prospectus supplement
5:20pm
entity of any kind.
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation … or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective
424B3
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
29 Dec 23
Prospectus supplement
5:17pm
entity of any kind.
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation … or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective
424B3
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
29 Dec 23
Prospectus supplement
5:15pm
entity of any kind.
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation … or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective
8-K
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
29 Dec 23
Entry into a Material Definitive Agreement
5:00pm
entity of any kind.
“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation … or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective
424B3
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
10 Oct 23
Prospectus supplement
5:41pm
be construed to preclude you from filing a complaint with or participating in or cooperating with an investigation by the United States Equal Employment … with such a complaint or investigation, including any related court litigation. Furthermore, nothing in this Agreement, including the Release, prohibits you from
424B3
EX-10.1
lnjrb9sh
10 Oct 23
Prospectus supplement
5:31pm
424B3
EX-10.1
l7m8w vupqy
10 Oct 23
Prospectus supplement
5:31pm
8-K
EX-10.1
0th677p024jmhaxj7z
6 Oct 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.2
1wqlwgxfi7qsf2 67w
1 Aug 23
Comera Life Sciences Announces $4.1 Million
4:08pm
8-K
EX-10.1
lb6lvt9 yiz
1 Aug 23
Comera Life Sciences Announces $4.1 Million
4:08pm
424B3
ac31rkfci2zqcm 328y
31 Mar 23
Prospectus supplement
4:34pm
424B3
gtf34zgqau1j7c6m
31 Mar 23
Prospectus supplement
4:34pm
424B3
lw1i9 mv66an0r
31 Mar 23
Prospectus supplement
4:32pm
424B3
m4xwui g0ea8asdlggpb
14 Nov 22
Prospectus supplement
5:19pm
424B3
1hxzo
14 Nov 22
Prospectus supplement
5:15pm
424B3
x8mrgpo3yn 5x8iibcg
14 Nov 22
Prospectus supplement
5:09pm
424B3
ibe ufc2x
14 Nov 22
Prospectus supplement
4:50pm
424B3
g9w8z0f8fk5fh 5qb
15 Sep 22
Prospectus supplement
4:09pm